Losartan therapy for cardiac disease in paediatricMarfan syndrome
- PMID: 26333075
- DOI: 10.1111/jpc.12823
Losartan therapy for cardiac disease in paediatricMarfan syndrome
Abstract
A case of severe early-onset Marfan syndrome (MFS) led us to ask the question: 'Should an ARB, particularly losartan [intervention], compared with beta blockade alone [comparison], be commenced in all paediatric MFS patients [patient] with aortic root dilatation [outcome]?' The current literature was critically appraised to address this question.
Keywords: cardiology; genetics; pharmacology.
© 2015 The Authors. Journal of Paediatrics and Child Health © 2015 Paediatrics and Child Health Division (Royal Australasian College of Physicians).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical